Medgenics: ESGCT Presentation (Medgenics) - Sep 26, 2015 - "MG-EP-RF-02 Key data"; "10 patients implanted (6 low dose, 4 mid dose)- data available for 9"; "Age range: 26yr-76yr average: 59yr"; "7 male, 3 Female"; "Low dose: 5/6 at or above 5 months"; "One patient at 14 months post implantation"; "As of Aug 31: Average duration in low dose: 6.8 months"; "As of Aug 31: 5/10 overall patients in the study are still ongoing"; "One patient in the mid dose cohort had to undergo phlebotomy 3 times d/t Hb exceeding 13"
P1/2 data • Biosimilar
|